mPhase Technologies Expands Nanotechnology Portfolio;
Agreement Struck with Lucent Technologies R&D Unit to Develop Ultra Sensitive
Magnetometers
NORWALK, Conn.--(BUSINESS WIRE)--March 10, 2005--mPhase Technologies (OTC:XDSL)
today announced it has reached an agreement with the Bell Labs research and
development arm of Lucent Technologies (NYSE:LU) to co-develop and commercialize
uncooled magnetic ultra-sensitive sensors for a host of defense and civilian
applications.
The sensors, technically referred to as magnetometers, are based on Micro
Electro Mechanical Systems (MEMS), using designs based on fundamental
breakthroughs made in the past few years at Bell Labs using the facilities of
the New Jersey Nanotechnology Consortium (NJNC). Initial tests of these MEMS
magnetometers indicate sensitivities 1000 times those achieved in presently
available uncooled magnetometers. Based on MEMS technology, these devices will
be small, rugged, and inexpensive and will create a new generation of uncooled
ultrasensitive magnetic field sensors.
We are thrilled to expand our already significant Bell Labs agreements to
develop new disruptive technology, said Ronald A. Durando, mPhase's CEO. This
magnetometer technology is a leap forward in detection and identification
technology. It is expected to have consequential impact in the military
electronics industry including applications in homeland security. Commercial
applications envisioned range from inexpensive navigation components for mobile
phones, to sensing devices for identification. Other applications could include
a wide range of diagnostic medical devices.
mPhase is already collaborating with Bell Labs in the development of a
nanotechnology-based power cell that may serve as a power source for the
magnetometers and other applications.
The agreement with mPhase to develop practical super-sensitive magnetometers
highlights the value of Bell Labs' role as host of the New Jersey Nanotechnology
Consortium, said David Bishop, NJNC President and Bell Labs Vice President of
Nanotechnology. The NJNC enables Bell Labs to team with companies like mPhase to
bring to market innovations that not only enhance U.S. competitiveness, but also
drive economic activity in New Jersey.
About mPhase
mPhase Technologies Inc. (OTC: XDSL) develops and commercializes next-generation
telecommunications and nanotechnology solutions, delivering novel systems to the
marketplace that advance functionality and reduce costs. In telecommunications,
the Company's mPhase TV+ platform cost-effectively and reliably delivers
entertainment digital television, high-speed Internet access and traditional
telephone service over existing copper telephone lines. mPhase also offers a
growing line of innovative DSL component products, such as the iPOTS, designed
to help service providers lower the provisioning and operating costs associated
with DSL. The company is bringing nanotechnology out of the laboratory and into
the market with a planned innovative, long-life power cell.
More information is available at the mPhase Web site at www.mPhaseTech.com.
About Bell Labs and Lucent Technologies
Bell Labs is the leading source of new communications technologies. It has
generated more than 30,000 patents since 1925 and has played a pivotal role in
inventing or perfecting key communications technologies, including transistors,
digital networking and signal processing, lasers and fiber-optic communications
systems, communications satellites, cellular telephony, electronic switching of
calls, touch-tone dialing, and modems. Bell Labs scientists have received six
Nobel Prizes in Physics, nine U.S. National Medals of Science and eight U.S.
National Medals of Technology. For more information about Bell Labs, visit its
Web site at www.bell-labs.com.
Lucent Technologies designs and delivers the systems, services and software that
drive next- generation communications networks. Backed by Bell Labs research and
development, Lucent uses its strengths in mobility, optical, software, data and
voice networking technologies, as well as services, to create new
revenue-generating opportunities for its customers, while enabling them to
quickly deploy and better
manage their networks. Lucent's customer base includes communications service
providers, governments and enterprises worldwide. For more information on Lucent
Technologies, which has headquarters in Murray Hill, N.J., U.S.A, visit
www.lucent.com.
About The New Jersey Nanotech Consortium
The New Jersey Nanotechnology Consortium (NJNC) provides rapid and
cost-effective access to world-class nanotechnology research and development
services. A subsidiary of Lucent Technologies, based at and run by Bell Labs,
the NJNC conducts basic and applied nanotechnology research and provides
fabrication and packaging capabilities, fulfilling its mission of bringing
nanotech ideas from concept to commercialization. The NJNC is also supported by
the State of New Jersey, enabling participation of local research universities
including Rutgers University, New Jersey Institute of Technology and The
University of Medicine and Dentistry of New Jersey.
Safe Harbor Statement
This news release contains forward-looking statements related to future growth
and earnings opportunities. Such statements are based upon certain assumptions
and assessments made by management of both companies in light of current
conditions, expected future developments and other factors they believe to be
appropriate. Actual results may differ as a result of factors over which the
companies have no control.
CONTACT: TMI
Sam Gronner, 201-592-7896
sam@technovative.com
SOURCE: mPhase Technologies
|